IMAN NABIL HANNA

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry UPLAND, CA NPI 1831247766

General Payments — all program years on this page

$5,262.35

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 284
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $510.90 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $510.9019

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,248.1776
2019 $1,857.1187
2020 $457.2626
2021 $161.708
2022 $597.7345
2023 $429.4823
2024 $510.9019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103874744 ABBVIE INC. $18.31 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103874746 ABBVIE INC. $18.49 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904875 Otsuka America Pharmaceutical, Inc. $12.39 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904877 Otsuka America Pharmaceutical, Inc. $21.25 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904879 Otsuka America Pharmaceutical, Inc. $21.03 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904881 Otsuka America Pharmaceutical, Inc. $21.11 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904883 Otsuka America Pharmaceutical, Inc. $5.89 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904885 Otsuka America Pharmaceutical, Inc. $8.54 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904887 Otsuka America Pharmaceutical, Inc. $6.95 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904889 Otsuka America Pharmaceutical, Inc. $10.10 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904891 Otsuka America Pharmaceutical, Inc. $7.64 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904893 Otsuka America Pharmaceutical, Inc. $11.79 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904895 Otsuka America Pharmaceutical, Inc. $20.02 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145922910 Lundbeck LLC $19.31 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896139 Supernus Pharmaceuticals, Inc. $22.91 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148285749 Axsome Therapeutics, Inc. $21.79 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148285751 Axsome Therapeutics, Inc. $125.00 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150808888 Neurocrine Biosciences, Inc. $125.10 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150879085 Neurocrine Biosciences, Inc. $13.28 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.